Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a deployment of a newer version of the page or site template. This change appears to be a metadata update rather than a modification to the study content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor site/build update.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the prior Revision: v3.6.4, indicating a small software update rather than any changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe site footer now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a platform update with no changes to the study content.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a maintenance update to the page. There are no visible content or functionality changes indicated by the provided data.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, signaling a recent update to the study details page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.